Prevention of pocket related complications with fibrin sealant in patients undergoing pacemaker implantation who are receiving anticoagulant treatment

Europace

Volumn 7, Issue 4, 2005, Pages 374-379

  Milic, Dragan J ^a   Perisic, Zoran D ^a   Zivic, Sasa S ^a   Stanojkovic, Zoran A ^b   Stojkovic, Aleksander M ^a   Karanovic, Nevena D ^a   Krstic, Nebojsa H ^a   Salinger, Sonja S ^a  

^a CLINICAL CENTER NIS   (Serbia)

^b Blood Transfusion Institute   (Serbia)

Author keywords

Complications; Fibrin sealant; Pacemaker implantation; Pocket haematoma

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; APROTININ; BLOOD CLOTTING FACTOR 12; CALCIUM CHLORIDE; FIBRIN GLUE; FIBRINOGEN; FIBRONECTIN; HEMOSTATIC AGENT; HEPARIN; THROMBIN; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; AORTA VALVE DISEASE; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CRYOPRECIPITATE; DRUG EFFICACY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEMATOMA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG TERM CARE; MALE; MITRAL VALVE DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; TREATMENT OUTCOME; WOUND CARE; WOUND CLOSURE; YUGOSLAVIA;

EID: 20344369259     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eupc.2005.03.007     Document Type: Article

References (25)

1. J. Hirsh J.E. Dalen D. Deykin et al. Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 108 1995 231-246
2. R.C. Becker J. Ansell Antithrombotic therapy: An abbreviated reference for clinicians. Arch Intern Med 155 1995 149-161
3. A.S. Al-Khadra Implantation of pacemakers and implantable cardioverter defibrillators in orally anticoagulated patients. Pacing Clin Electrophysiol 26 2003 511-514
4. M. Kiviniemi M. Pirnes H. Eranen et al. Complications related to permanent pacemaker therapy. Pacing Clin Electrophysiol 22 1999 711-720
5. G.F. Michaud F. Pelosi Jr. M.D. Noble et al. A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation. J Am Coll Cardiol 35 2000 1915-1948
6. S. Bergel Über die Wirkung des Fibrins Dtsch Med Wochenschr. 35 1909 663-665
7. T. Castberg Complications from the pacemaker pocket: Prophylaxis, treatment and results Acta Med Scand 596 1976 51-54
8. P. Cacoub P. Leprince P. Nataf et al. Pacemaker infective endocarditis Am J Cardiol 82 1998 480-484
9. G.L. Bluhm Pacemaker infections: A 2-year follow-up of antibiotic prophylaxis. Scand J Thorac Cardiovasc Surg 19 1985 231-235
10. D. Pfeiffer W. Jung W. Fehske et al. Complications of pacemaker defibrillator devices: Diagnosis and management. Am Heart J 127 1994 1073-1080
11. A. Chauhan A.A. Grace S.A. Newell et al. Early complications after dual chamber versus single chamber pacemaker implantation. Pacing Clin Electrophysiol 17 1994 2012-2015
12. C.K. Mok J. Boey R. Wang et al. Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: A prospective randomized clinical trial. Circulation 72 1985 1059-1063
13. S.C. Cannegieter F.R. Rosendaal E. Briet Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 89 1994 635-641
14. Group EAFTS Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke: EAFT (European Atrial Fibrillation Trial) Study Group Lancet 342 1993 1255-1262
15. C. Kearon J. Hirsh Management of anticoagulation before and after elective surgery. N Engl J Med 336 1997 1506-1511
16. R.T. Tidrick E.D. Warner Fibrin fixation of skin transplants. Surgery 15 1944 90-95
17. H. Matras H.P. Dinges H. Lassmann et al. Zur nahtlosen interfaszikulären Nerventransplantation im Tierexperiment Wien Med Wochenschr 122 1972 517-523
18. K. Gdanietz I. Gutsche The use of fibrin sealant in surgery. Acta Chir Austriaca 3 1991 95-99
19. H.P. Spängler J. Holle E. Moritz et al. Experimentelle Untersuchungen und erste klinische Erfahrungen über die totale Blutstillung mittels hochkonzentriertem Fibrin. Österr Ges Chir 1975 605-610
20. D.F. Thompson N.A. Letassy G.D. Thompson Fibrin glue: A review of its preparation, efficacy, and adverse effects as a topical hemostat. Drug Intell Clin Pharm 22 1988 946-952
21. R.I. Senderoff M.-T. Sheu T.D. Sokoloski Fibrin based drug delivery systems. J Parenter Sci Technol 45 1991 2-6
22. A. Dresdale E.A. Rose V. Jeevanandam et al. Preparation of fibrin glue from single-donor fresh-frozen plasma. Surgery 97 1985 750
23. G.B. Schreiber M.P. Busch S. Kleinman et al. The risk of transfusion - Transmitted viral infections. N Engl J Med 334 1996 1685
24. E.M. Lackritz G.A. Satten J. Aberle-Grasse et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 333 1995 1721
25. W.D. Spotnitz Commercial fibrin sealants in surgical. care Am J Surg 182 2001 188